world
Pharma major plummets over 10% after third trial disappointment in a week
CNBC
September 8, 2026
via CNBCYou're reading one story from Newsaly
Newsaly brings together 60,000+ newspaper articles, 30,000+ podcasts and 10,000+ magazine articles from around the world.
A World Of News, One Window.
Explore Today's News
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
Read the full story
Explore More On Newsaly
Voices (0)
Share a 15-second voice reaction. Voices automatically disappear after 10 days.
Sign in to record a voice on this article.
Be the first to share a voice on this article.